Urteste S.A. (WSE:URT)
Poland · Delayed Price · Currency is PLN 46.60
+2.60 (5.91%)
Jul 24, 2026, 3:42 PM CET
Urteste Market Cap
Urteste has a market cap or net worth of 71.12 million as of July 24, 2026. Its market cap has increased by 3.17% in one year.
Market Cap
71.12M
Enterprise Value
68.13M
Revenue
2.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
46.60
ChartMarket Cap Chart
Since October 27, 2021, Urteste's market cap has decreased from 110.64M to 71.12M, a decrease of -35.72%. That is a compound annual growth rate of -8.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 71.12M | 29.35% |
| Dec 30, 2025 | 54.98M | -59.03% |
| Dec 30, 2024 | 134.20M | -12.66% |
| Dec 29, 2023 | 153.65M | 70.57% |
| Dec 30, 2022 | 90.08M | -17.62% |
| Dec 30, 2021 | 109.35M | -1.16% |
| Oct 27, 2021 | 110.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioceltix | 542.16M |
| Captor Therapeutics Spolka Akcyjna | 479.05M |
| Ryvu Therapeutics | 346.80M |
| BIOTON | 330.15M |
| Synthaverse | 208.37M |
| Poltreg | 138.45M |
| Molecure | 122.59M |
| Mabion | 119.12M |